CorMedix Inc.
Healthcare / Biotechnology
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was incorporated in 2006 and is based in Parsippany, New Jersey.
Performance
--
Today 0.00 (0.00%)
CRMD
Metrics
Market Cap610M
Latest Price$7.82
Previous Close$7.76
Volume664K
52 Week High$13.02
52 Week Low$6.13
52 Week Change-33.11%
Average Volume1.2M
Revenue462M
EPS2.2
P/E Ratio3.555
Forward P/E22.343
Price/Book1.318
Profit Margin0.40%
Operating Margin0.42%
Return on Equity0.55%
Dividend Yield0.00%